Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessCore Laboratories Inc. (NYSE:CLB) Quarterly Earnings Preview

Core Laboratories Inc. (NYSE:CLB) Quarterly Earnings Preview

Add to Favorite
Added to Favorite


Core Laboratories Inc. (NYSE:CLB) is expected to release its quarterly earnings on October 23, 2024, with an estimated EPS of $0.25 and projected revenue of $134.45 million.
The company has a history of surpassing earnings estimates, with an average earnings surprise of 11.76% over the past two quarters.
Financial metrics reveal a P/E ratio of approximately 31.24, a price-to-sales ratio of about 1.70, and a debt-to-equity ratio of approximately 0.66.

Core Laboratories Inc. (NYSE:CLB) stands out in the oil and gas field services industry, offering expertise in reservoir description and production enhancement. Based in Houston, Texas, CLB’s services and products are designed to optimize oil and gas production. The company’s upcoming quarterly earnings, set for release on October 23, 2024, are highly anticipated, with Wall Street analysts projecting an EPS of $0.25 and revenue expectations of around $134.45 million.

The forthcoming earnings report is expected to demonstrate a revenue increase from the previous quarter, as noted by Zacks. This growth is attributed to the company’s focus on reducing costs associated with services, product sales, and general administrative expenses. In the last quarter, CLB reported revenues of $130.6 million, surpassing consensus estimates, a trend that may continue.

Core Laboratories has consistently beaten earnings estimates, with an impressive average earnings surprise of 11.76% over the last two quarters. In the most recent quarter, the company reported an EPS of $0.22, exceeding the Zacks Consensus Estimate of $0.21 per share. This track record suggests that CLB may extend its streak of earnings surprises in the upcoming report.

The company’s financial health and valuation are highlighted by several key metrics. With a P/E ratio of approximately 31.24, investors show a willingness to pay a premium for CLB’s earnings. The price-to-sales ratio stands at about 1.70, indicating the market’s valuation of the company relative to its sales. Moreover, a debt-to-equity ratio of approximately 0.66 points to a moderate level of debt, while a current ratio of around 2.39 signals a robust ability to cover short-term liabilities.

The stock’s performance following the earnings release will largely hinge on whether the actual results surpass or fall short of analyst estimates. A positive earnings surprise could boost the stock price, whereas a miss might lead to a decline. The long-term impact on the stock price and future earnings expectations will also be influenced by the management’s discussion of business conditions during the earnings call.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Lifecore Biomedical, Inc. (NASDAQ: LFCR) Quarterly Earnings Preview

Earnings per Share (EPS) loss is anticipated to be...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Faces Financial Challenges

Earnings per Share (EPS) of -$0.07 missed the estimated...

Arthur J. Gallagher & Co. (NYSE: AJG) Insider Purchase and Stock Performance

Gallagher Patrick Murphy, COO of Arthur J. Gallagher &...